KATALYST PUBLISHING GROUP
  • Home
  • About Us
  • Submit Manuscript
  • Journals
  • Video Articles
  • Reprints
  • Contact Us

Welcome To KATALYST PUBLISHING GROUP

Profile

Connect With Us

Journal of Current Trends in Pharmaceutical Sciences (JCTPS)

  • Home
  • Journal of Current Trends in Pharmaceutical Sciences (JCTPS)
  • Home
  • Editorial Board
  • Guide for Authors
  • Articles Inpress
  • Current Issue
  • Archive
  • Submit Manuscript

Journal of Current Trends in Pharmaceutical Sciences (JCTPS)

The Journal of Current Trends in Pharmaceutical Sciences is a peer-reviewed, open access international journal that publishes innovative research articles covering a wide range of topics in pharmaceutical sciences. From drug discovery to development, evaluation, and regulatory approval, we aim to showcase cutting-edge advancements in the field. Small drug molecules, biotechnology products (such as genes, peptides, proteins, and vaccines), and genetically engineered cells plays a crucial role in the research published in our journal.

The Journal of Current Trends in Pharmaceutical Sciences welcomes a wide range of submissions, including Original Research Articles, Review Articles, Mini Reviews, Rapid Communication, Opinions, and Editorials. Our journal provides a platform for pharmacists, biologists, cancer researchers, chemists, medical practitioners, ophthalmologists, pathologists, research scientists, and professionals in the pharmaceutical sciences and pharmaceutical industries to share their findings. We encourage authors to choose the format that best suits their research and communication objectives to effectively disseminate their findings.

All articles published in Journal of Current Trends in Pharmaceutical Sciences are freely and permanently accessible online, ensuring immediate availability to readers worldwide. We believe in removing subscription charges and registration barriers, allowing unrestricted access to valuable research and fostering the global dissemination of knowledge.

Topics encompass a wide range and are not limited to the following:

Biopharmaceutics

Computational Biopharmaceutics

Drug Disposition

Engineering

Formulation Design

Molecular Biopharmaceutics

Natural Product Research

Novel Drug Delivery and Targeting

Pharmaceutical / Medicinal Chemistry

Pharmaceutical Analysis

Pharmaceutical Technology

Pharmaceutics

Pharmacodynamics

Pharmacogenomics

Pharmacognosy

Pharmacokinetics

Pharmacology

Preformulation

Editorial Board

Dr. Chung-Yi Chen Ph.D

Dr. Chung-Yi Chen Ph.D

Dean and Professor
School of Medical and Health Sciences
Fooyin University, Taiwan

Dr. David R Luke

Dr. David R Luke

Senior Advisor, Pharmaceutical Research & Development
Charlestown
Rhode Island, USA

Dr. Rasha Ezzat Mostafa, Ph.D

Dr. Rasha Ezzat Mostafa, Ph.D

Associate professor,
Pharmacology Department, Medical Research Division,
National Research Centre, 33 ELBohouth St. (former EL Tahrir St.),
P.O. 12622, Dokki, Giza, Egypt

Prof. Takashiro Akitsu

Prof. Takashiro Akitsu

Department of Chemistry
Faculty of Science
Tokyo University of Science
Japan

Dr. Attapon Cheepsattayakorn

Dr. Attapon Cheepsattayakorn

10th Zonal Tuberculosis and Chest Disease Center
Department  of Disease Control
Ministry of Public Health,
Thailand

Dr. Heba Abdel Hady Abdel Raouf, Ph.D

Dr. Heba Abdel Hady Abdel Raouf, Ph.D

Researcher, Medicinal Chemistry Department,
Theodor Bilharz Research Institute (TBRI) Warrak El-Hadar,
Giza, Egypt

Dr. Mohamed Azmi Hassali

Dr. Mohamed Azmi Hassali

Professor of Social and Administrative Pharmacy
School of Pharmaceutical Sciences
Universiti Sains
Malaysia

Dr. Yusuf Tutar

Dr. Yusuf Tutar

University of Health Sciences Faculty of Pharmacy, Biochemistry Division & Health Sciences Institute,
Molecular Medicine Program Istanbul,
Turkey

Guide For Authors

The Journal of Current Trends in Pharmaceutical Sciences welcomes manuscript submissions for publication, adhering to the guidelines for the uniform requirements for manuscripts submitted to Journals. We encourage authors to follow these guidelines while preparing their manuscripts for submission.

Manuscripts submitted to the Journal should be original and not published or under consideration elsewhere. The acceptance of manuscripts is based on the recommendations of referees. Published papers become the exclusive property of Clinical Research and are subject to journal copyright.

You may submit manuscripts online at https://www.katalystpublishers.com/submit-manuscript or you may send the article as an email attachment to  katalystpublishinggroup@gmail.com

Open Access Policy

Research papers published in both electronic and print versions are freely accessible for viewing, copying, and printing by individual academicians and researchers. We believe in open access to knowledge and encourage widespread dissemination of research findings to foster collaboration and progress in the academic community.

Disclaimer

The management of The Journal of Current Trends in Pharmaceutical Sciences disclaims any responsibility for the statements and opinions expressed by the authors in their articles. Reproduction of any material, in any form, is strictly prohibited without the explicit permission of the journal.

This manuscript presents original work that has not been published, in whole or in part, in any print or electronic media. It is also not under consideration for publication elsewhere, except as an abstract in conference proceedings.

Authors designated for this manuscript must fulfill the following criteria:

Preparation of Manuscripts

Manuscripts should be organized into the following sections: Title Page, Abstract, Introduction, Materials and Methods, Results/Observations, Discussion, Acknowledgments, References, Tables, Figures, and Legends. All manuscripts must be written in English and pages should be numbered consecutively, starting from the title page.

Please submit the original manuscript copy, including figures, to the editorial office online or as an email attachment to the provided email address.

If manuscripts have already been submitted via email, there is no need to send hard copies by mail.

Title Page:

The title page of the manuscript should include the full title, author(s) names, affiliation(s) with the institute where the work was conducted, running title, and contact details of the corresponding author. Additionally, include 3-8 keywords that highlight the main themes of the manuscript.

Abstract:

The abstract should provide a concise summary within a limit of 250 words. It should be written in complete sentences and present factual information to provide a comprehensive overview of the study.

Abbreviations:

Units of measurement should adhere to the prescribed abbreviations listed below: For other abbreviations and symbols, please refer to the recommended guidelines on units, symbols, and abbreviations provided in "A Guide for Biological and Medical Editors and Authors (The Royal Society of Medicine London 1977)."

Acknowledgment:

Grant details, Funding Details, etc should be included.

Conflict of Interest:

Conflict of interest must be included. If there is no conflict of interest, please add the following statement: “The authors have no conflict of financial interest.”

References:

At the end of the manuscript, include a comprehensive list of all references cited in the text. The referencing style should follow the Vancouver agreement. References should be numbered sequentially based on their first mention in the text, identified by Arabic numerals enclosed in square brackets. Authors are responsible for verifying the accuracy of all cited references, ensuring the inclusion of all authors.

Tables:

Tables should not be submitted as photographs or scanned documents. Number the tables consecutively based on their first mention in the text and provide a concise title for each table. Tables should be typed on separate sheets, and any explanatory details should be placed as footnotes. Use short or abbreviated headings for each column.

Figures:

List all figures together. Figures should be numbered and must not exceed the dimensions of 16.5 x 22.0 cm. For optimal reproduction, only high-quality drawings and original photographs are accepted. If possible, group multiple illustrations on a single page. Photomicrographs should include internal scale markers, and symbols, arrows, or letters used in the images should be clearly distinguishable from the background. Electronically submitted black and white half-tone and color illustrations should have a final resolution of 300 dpi after scaling, while line drawings require a resolution of 800-1200 dpi.

Article Processing Charge (APC):Upon acceptance of an article for publication, the submitting author is responsible for the Article Processing Charges (APCs). These charges cover peer review, editorial services, production, and technology, ensuring high-quality publishing. APCs contribute to visibility through indexing, enable marketing efforts, and sustain the financial health of journals, fostering continued open-access availability.Once the payment is processed, the journal does not issue refunds under any circumstances.

Galley Proofs:

Unless specified otherwise, galley proofs will be sent to the first-named author. Authors are kindly requested to review and return the galley proofs within 48 hours of receipt.

Reprints:

Reprints can be purchased upon request. To order reprints, please submit the request along with the corrected galley proofs. Please note that reprints are not provided free of charge. The Reprint Order Form and Price List will be included with the galley proofs.

Referees:

Typically, two experienced referees from our panel review submitted manuscripts. Contributors may suggest three qualified reviewers who are knowledgeable in the subject matter of the manuscript. However, these reviewers should not be affiliated with the same institution(s) as the contributors and should not have co-published manuscripts with the contributors in the past 10 years.

Ethics:

For experiments involving human subjects, please state whether the procedures adhered to the ethical standards set by the responsible committee on human experimentation (institutional or regional) and the Helsinki Declaration of 1975, revised in 2000. Avoid using patients' names, initials, or hospital numbers, especially in illustrative material. In the case of experiments on animals, indicate whether the institution's or a national research council's guidelines or any relevant national laws on the care and use of laboratory animals were followed.

Articles Inpress

Short Communication

Interleukin-6 Inhibitors in Treating Severe COVID-19

Dr. Attapon Cheepsattayakorn* and Ruangrong Cheepsattayakorn

PDF

Short Communication

Corona Virus Containment Response: A Massive Public Health Ethics Failure

Dr. Eugene J Koprowski

PDF

Research Article

Epidemiology, Virology, Pathogenesis and Treatment of Novel COVID-19

Farouk S. Nas, Muhammad Ali*, Lurwan Mu’azu and Muhammad S. Abdallah

PDF

Short Communication

The Role of Oxytocin (Oxy) for Pain and Stress

Dr. Bogdan Feliks Kania

PDF

Review Article

A Review on in vitro and Clinical Studies Published on Remdesivir After COVID-19 Outbreak

Drashti Patel and Bappaditya Chatterjee*

PDF

Research Article

COVID-19 infection: The risk of a coagulation disorder is lower in children than in adults

Aysel Simon FLORESCU, Niculae ION NEDELCU, Emanoil CESUSU, Petre Iacob CALISTRU, Magdalena GEORGE and    David VAN THIEL*

PDF

Research Article

The use of the public domain to investigate the populations perceptions and responses to publically identified behaviors designed to limit COVID-19 virus infection: A telephone survey of individuals d

Aysel Simin FLORESCU, Niculae ION NEDELCU, Emanoil CEAUSU, Petre Iacob CALISTRU, Magdalena GEORGE and    David H VAN THIEL*

PDF

Current Issue

Archive

Research Article

The use of the public domain to investigate the populations perceptions and responses to publically identified behaviors designed to limit COVID-19 virus infection: A telephone survey of individuals d

Aysel Simin FLORESCU, Niculae ION NEDELCU, Emanoil CEAUSU, Petre Iacob CALISTRU, Magdalena GEORGE and David H VAN THIEL*

PDF

Research Article

COVID-19 infection: The risk of a coagulation disorder is lower in children than in adults

Aysel Simon FLORESCU, Niculae ION NEDELCU, Emanoil CESUSU, Petre Iacob CALISTRU, Magdalena GEORGE and David VAN THIEL*

PDF

Review Article

A Review on in vitro and Clinical Studies Published on Remdesivir After COVID-19 Outbreak

Drashti Patel and Bappaditya Chatterjee*

PDF

Short Communication

The Role of Oxytocin (Oxy) for Pain and Stress

Dr. Bogdan Feliks Kania

PDF

Research Article

Epidemiology, Virology, Pathogenesis and Treatment of Novel COVID-19

Farouk S. Nas, Muhammad Ali*, Lurwan Mu’azu and Muhammad S. Abdallah

PDF

Short Communication

Corona Virus Containment Response: A Massive Public Health Ethics Failure

Dr. Eugene J Koprowski

PDF

Short Communication

Interleukin-6 Inhibitors in Treating Severe COVID-19

Dr. Attapon Cheepsattayakorn* and Ruangrong Cheepsattayakorn

PDF

Submit Manuscript

* These fields are required

KATALYST PUBLISHING GROUP

Katalyst Publishing Group is an independent, open access scientific publisher. Our mission is clear: to empower authors and captivate readers by circulating meticulously scientifically researched, cutting-edge information across the areas of medical, biological, pharmaceutical, engineering, and technology-oriented subjects.

Important Links

  • About Us
  • Manuscript Submission
  • List of all Journals
  • Contact Us
  • Terms and Conditions
  • Privacy Policy

Contact Us

  • Email katalystpublishers@gmail.com

  • Phone +17027276831

  • Address 1043 Garland Ave Unit C #769, San Jose, CA 95126, United States

© 2023 KATALYST PUBLISHING GROUP, All Rights Reserved.

  • Privacy Policy
  • Terms and Conditions
  • Contact Us